Adipose tissue gene expression of adiponectin, tumor necrosis factor-α and leptin in metabolic syndrome patients with coronary artery disease

Internal Medicine

Volumn 50, Issue 8, 2011, Pages 805-810

  Gormez, Selcuk ^a   Demirkan, Ayse ^b   Atalar, Fatmahan ^c   Caynak, Baris ^d   Erdim, Refik ^a   Sozer, Volkan ^e   Gunay, Demet ^a   Akpinar, Bellhan ^d   Ozbek, Ugur ^c   Buyukdevrim, Ahmet Sevim ^f  

^a FLORENCE NIGHTINGALE HOSPITAL   (Turkey)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c ISTANBUL UNIVERSITY   (Turkey)

^d ISTANBUL BILIM UNIVERSITY   (Turkey)

^e YILDIZ TECHNICAL UNIVERSITY   (Turkey)

^f ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Atherosclerosis; Chemokines; Genes; Inflammation; Metabolic syndrome

Indexed keywords

ADIPONECTIN; LEPTIN; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORRELATIONAL STUDY; DOWN REGULATION; EPICARDIUM; FEMALE; GENE EXPRESSION; GENE LOCATION; HEART VALVE SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PROSPECTIVE STUDY; SUBCUTANEOUS FAT; UPREGULATION;

ADIPONECTIN; ADIPOSE TISSUE; AGED; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; FEMALE; GENE EXPRESSION; HUMANS; LEPTIN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PERICARDIUM; PROSPECTIVE STUDIES; RNA, MESSENGER; SUBCUTANEOUS FAT; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79955565366     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.50.4753     Document Type: Article

References (34)

1. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 365: 1415-1428, 2005.
2. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 414: 782-787, 2001.
3. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new world idendefinition. A Consensus Statement from the International Diabetes Federation. Diabet Med 23: 469-480, 2006.
4. Alberti KGMM, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120: 1640-1645, 2009.
5. Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med 119: 812-819, 2006.
6. Gami AS, Witt BJ, Howard DE, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 49: 403-414, 2007.
7. Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocrinol Metab 11: 327-332, 2000.
8. Iacobellis G, Pistilli D, Gucciardo M, et al. Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease. Cytokine 29: 251-255, 2005.
9. Mazurek T, Zhang L, Zalewski A, et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 108: 2460-2466, 2003.
10. Chandran M, Phillips SA, Ciaraldi T, Henry RR. Adiponectin: more than just another fat cell hormone? Diabetes Care 26: 2442-2450, 2003.
11. Diez JJ, Iglesias P. The role of the novel adipocyte-derived hormone adiponectinin human disease. Eur J Endocrinol 148: 293-300, 2003.
12. Nishimura F, Iwamoto Y, Mineshiba J, Shimizu A, Soga Y, Murayama Y. Periodontal disease and diabetes mellitus: the role of tumor necrosis factor-alpha in a 2-way relationship. J Periodontol 74: 97-102, 2003.
13. Ruan H, Miles PD, Ladd CM, et al. Profiling gene transcription in vivo reveals adipose tissue as an immediate target of tumor necrosis factor-f: implications for insulin resistance. Diabetes 51: 3176-3188, 2002.
14. Guzik TJ, Mangalat D, Korbut R. Adipocytokines: novel link between inflammation and vascular function? J Physiol Pharmacol 57: 505-528, 2006.
15. Lofgren P, Harmelen V van, Reynisdottir S, et al. Secretion of tumor necrosis factor-alpha shows a strong relationship to insulinstimulated glucose transport in human adipose tissue. Diabetes 49: 688-692, 2000.
16. Ahima RS, Flier JS. Leptin. Annu Rev Physiol 62: 413-437, 2000.
17. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 395: 763-770, 1998.
18. Knudson JD, Payne GA, Borbouse L, Tune JD. Leptin and mechanisms of endothelial dysfunction and cardiovascular disease. Current Hypertension Reports 10: 434-439, 2008.
19. Third Report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Adult Treatment Panel III. Final report. Circulation 106: 3143-3421, 2002.
20. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 27: 1487-1495, 2004.
21. Vural B, Atalar F, Ciftci C, et al. Presence of fatty-acid-binding protein 4 expression in human epicardial adipose tissue in metabolic syndrome. Cardiovasc Pathol 17: 392-398, 2008.
22. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408, 2001.
23. Maury E, Brichard SM. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol 314: 1-16, 2010.
24. Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol Cell Endocrinol 316: 129-139, 2010.
25. Baker AR, da Silva NF, Quinn DW, et al. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol 5: 1-7, 2006.
26. Cornier M-A, Dabelea D, Hernandez TL, et al. The metabolic syndrome. Endocr Rev 29: 777-822, 2008.
27. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334: 292-295, 1996.
28. Jazet IM, Pijl H, Meinders AE. Adipose tissue as an endocrine organ: impact on insulin resistance. Neth J Med 61: 194-212, 2003.
29. Sundell J, Huupponen R, Raitakari OT, Nuutila P, Knuuti J. High serum leptin is associated with attenuated coronary vasoreactivity. Obes Res 11: 776-782, 2003.
30. Ouchi N, Kihara S, Arita Y, et al. Adiponectin, an adipocytederived plasma protein, inhibits endothelial NF-pB signaling through a cAMP-dependent pathway. Circulation 102: 1296-1301, 2000.
31. Loffreda S, Yang SQ, Lin HZ, et al. Leptin regulates proinflammatory immune responses. FASEB J 12: 57-65, 1998.
32. lau D, Yan H, Abdel-Hafez M, Kermouni A. Adipokines and the paracrine control of their production in obesity and diabetes. Int J Obes Relat Metab Disord 26: S111, 2002.
33. Virmani R, Kolodgie FD, Burke AP, et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 25: 2054-2061, 2005.
34. Chaowalit N. Epicardial adipose tissue: friendly companion or hazardous neighbour for adjacent coronary arteries? Eur Heart J 29: 695-697, 2008.